Jade Biosciences (JBIO) Other Accumulated Expenses (2020 - 2025)
Jade Biosciences (JBIO) reported Other Accumulated Expenses of $429,000 for Q1 2025, down 36.4% from $674,000 a year earlier but up 34.5% from the prior quarter.
Powered by 
Analysis
Jade Biosciences (JBIO) Other Accumulated Expenses (2020 - 2025) Analysis & Trends
At the end of FY2024, Jade Biosciences posted Other Accumulated Expenses of $319,000, down 70.7% from FY2023.
- Other Accumulated Expenses has a four-year compound annual growth rate of -23.8% (FY2020 to FY2024).
- By year, Other Accumulated Expenses came in at $1.09 million in FY2023 (+186.8%), $380,000 in FY2022 (+165.7%), $143,000 in FY2021 (-84.9%) and $946,000 in FY2020.
- Five-year quarterly Other Accumulated Expenses spans a low of $120,000 in Q2 2021 and a high of $1.09 million in Q4 2023.
- Year over year, Other Accumulated Expenses has now declined in each of the last three quarters, with growth averaging 34.1% over the last eight quarters.
- The high point for year-over-year Other Accumulated Expenses in five years was Q2 2022 (growth of 580.8%); the low point was Q4 2021 (a decline of 84.9%).
- Per Business Quant data, the three quarters before Q1 2025 came in at $319,000 (Q4 2024), $292,000 (Q3 2024) and $669,000 (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Jade Biosciences | 1.04 Bn | -265.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 429,000.00 |
| Dec 31, 2024 | 319,000.00 |
| Sep 30, 2024 | 292,000.00 |
| Jun 30, 2024 | 669,000.00 |
| Mar 31, 2024 | 674,000.00 |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | 439,000.00 |
| Jun 30, 2023 | 583,000.00 |
| Mar 31, 2023 | 252,000.00 |
| Dec 31, 2022 | 380,000.00 |
| Sep 30, 2022 | 254,000.00 |
| Jun 30, 2022 | 817,000.00 |
| Mar 31, 2022 | 1.02 Mn |
| Dec 31, 2021 | 143,000.00 |
| Sep 30, 2021 | 180,000.00 |
| Jun 30, 2021 | 120,000.00 |
| Dec 31, 2020 | 946,000.00 |
API Access
Jade Biosciences Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=JBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "JBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=JBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();